Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Globus Medical (GMED)
NYSE:GMED
Earnings Data
Report Date
May 13, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.78Last Year’s EPS
0.72Same Quarter Last Year
Moderate Buy
Based on 14 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 20, 2025
|% Change Since: -4.56%
|Next Earnings Date:May 13, 2025
Earnings Call Sentiment|Positive
Globus Medical reported a strong financial performance with record revenue and growth, successful product launches, and impressive enabling technology sales. The company is achieving significant synergies from the NuVasive merger and is on track to become debt-free. However, there were some challenges, including supply chain disruptions and foreign exchange headwinds. Overall, the sentiment is positive due to the outweighing highlights.Company Guidance
During the fourth quarter and full year 2024 earnings call, Globus Medical provided guidance on several key financial metrics. The company achieved record full-year revenue of $2.519 billion, a 61% increase over the prior year, and a non-GAAP EPS of $3.04, up 31% despite a 20% increase in diluted shares. Q4 revenue was $657 million, a 7% increase year-over-year, with non-GAAP EPS rising 40% to $0.84. The company reported a record free cash flow of $405 million for the year, a 145% increase, and $193 million for Q4, up 136%. For 2025, Globus projects standalone revenue between $2.66 billion and $2.69 billion, with non-GAAP EPS ranging from $3.40 to $3.50. Following the expected acquisition of Nevro Corp., which should close in late Q2 2025, anticipated 2025 revenue is adjusted to a range of $2.8 billion to $2.9 billion, with non-GAAP EPS of $3.10 to $3.40. The company also highlighted their success with product launches, including 18 new products in 2024, and expressed confidence in their strategic focus on integration, synergy capture, and future growth through innovation and operational excellence.Record-Breaking Revenue and Growth
Globus Medical achieved a record revenue of $2.519 billion for the full year 2024, indicating a 61% increase compared to the prior year.
Strong Financial Performance
Non-GAAP EPS increased by 31%, reaching a record $3.04 despite a 20% increase in diluted shares. Free cash flow hit an all-time high of $405 million, a 145% increase from the previous year.
Successful Product Launches
Globus launched 18 new products in 2024, including innovative surgical systems like QUARTEX MIS and ALLEGIANCE Retractor System, demonstrating a strong push in innovation.
Impressive Q4 Performance
Q4 sales reached $657 million, marking a 7% increase versus the prior year. Non-GAAP EPS increased by 40% to $0.84.
Enabling Technology Growth
Q4 enabling technology sales were $47 million, a 44% increase over the prior year, with a 47% increase in unit placements.
Debt-Free Status Achieved
The company plans to return to a debt-free status by the end of Q1 2025 by paying off $1 billion of debt from the NuVasive merger.
International Growth
The international spine implant business delivered 13% sales growth on a constant currency basis, driven by strong performance in Japan, UK, Italy, and Ireland.
---
GMED Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
GMED Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 20, 2025 | $84.12 | $80.28 | -4.56% |
| Nov 05, 2024 | $75.58 | $82.71 | +9.43% |
| Aug 06, 2024 | $69.05 | $70.53 | +2.14% |
| May 07, 2024 | $51.36 | $61.73 | +20.19% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Globus Medical (GMED) report earnings?
Globus Medical (GMED) is schdueled to report earning on May 13, 2025, TBA Not Confirmed.
What is Globus Medical (GMED) earnings time?
Globus Medical (GMED) earnings time is at May 13, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is GMED EPS forecast?
GMED EPS forecast for the fiscal quarter 2025 (Q1) is 0.78.
---